吡格列酮对链脲佐菌素诱导的糖尿病大鼠肾脏保护作用研究
被引量:2
出处
《中华内科杂志》
CAS
CSCD
北大核心
2003年第8期579-580,共2页
Chinese Journal of Internal Medicine
基金
天津市教委科研基金资助项目 (9910 0 6)
二级参考文献22
-
1Corton JC,Anderson SP, Stauber A. Centrol role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators. Ann Rev Pharmcal Toxicol, 2000, 40:491~518.
-
2Guan Y, Breyer MD.Peroxisome proliferator-activated receptors(PPARs): novel therapeutic targets in renal disease. Kidney Int, 2001, 60(1): 14~30.
-
3JUGE-Aubry CE, Hamma E, Siegrist-kaiser C, et al. Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor a by phosphorylation of a ligand-independent trans-activating domain. J Biol Chem, 1999,274(15): 10 505~10.
-
4Kersten S, seydoux J, peters JM, et al. Peroxisome proliferator-activated alpha mediates the adaptive response to fasting. J Clin Invest, 1999, 103(11):1489~98.
-
5Escher P, Wahli W. Peroxisome proliferator-activated receptors: Insight into multiple celluar functions. Mut Res, 2000,448(2): 121~38.
-
6Rieusset J, Andreelli F, Auboeuf D, et al. Insulin acutely regulates the expression of the peroxisome proliferator-activated receptor gamma in hunan adipocytes. Diabetes, 1999, 48(4):699~705.
-
7Braissant O, Foufelle F, Scotto C, et al. Differential expression of peroxisome proliferator-activated receptors (PPARS): Tissue distribution of PPAR - a, β, and γ in the adult rat. Endocrinology, 1996, 137(1): 354~66.
-
8Gregoire FM.Adipocyte differentiation: from fibroblast to en doerine cell. Exp Biol Med (Maywood), 2001, 226(11): 997~1002.
-
9Yamauchi T, Kamon J, Waki H, et al. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. J Biol Chem, 2001,276(44) :41245~54.
-
10Ouali F, Djouadi F, Merlet-Benichou C, et al. Diatary lipids regulate oxidation enzyme gene expression in the developing rat kidney. Am J Physiol, 1998, 275(5 pt 2): F777~84.
同被引文献12
-
1李贤厚,段滨红,王亦薇,冯琨,杨玉芝.罗格列酮治疗2型糖尿病合并肾病尿微量白蛋白的疗效观察[J].中国误诊学杂志,2004,4(9):1432-1432. 被引量:5
-
2叶任高,陆再英,主编.内科学[M].第6版.北京:人民卫生出版社,2005,28-30.
-
3Suzuki D, Toyoda M, Yamamoto N, et al. Relationship between the expression of advanced glyeation end-products (AGE) and the receptor for AGE (RAGE) mRNA in diabetic nephropathy. Intern Med, 2006, 45:435-441.
-
4Okada T, Wada J, Hida K, et al.Thiazolidinediones ameliorate diabetic nephropathy via cell cycle-dependent mechanisms. Diabetes, 2006,55: 1666 -1677.
-
5Marx N, Walcher D, Ivanova N, et al. Thiazolidinediones reduce endothelial expression of receptors for advanced glycation end products. Diabetes, 2004,53:2662-2668.
-
6Tang SC, Leung JC, Chan LY, et al. Activation of tubular epithelial cells in diabetic nephropathy and the role of the peroxisome proliferatoractivated receptor-gamma agonist. J Am Sec Nephrol, 2006,17:1633- 1643.
-
7Wendt TM, Tanji N, Guo J, et al. RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Am J Pathol, 2003,162 : 1123-1137.
-
8Jensen LJ, Denner L, Schrijvers BF, et al. Renal effects of a neutralising RAGE-antibody in long-term streptozotocin-diabetic mice. J Endocfinol, 2006,188:493-501.
-
9Bavirti S, Ghanaat F, Taydk JA. Peroxisome proliferator-activated receptor-gamma agonist increases both low-density lipoprotein cholesterol particle size and small high-density lipoprotein cholesterol in patientS with type 2 diabetes independent of diabetic control. Endocrine Practice, 2003,9:487-489.
-
10Ma LJ, Marcantoni C, Linton MF, et al. Peroxisome proliferator-activated receptor-γ, agonist troglitazone protects against nondiabetic glomerulosclerosis in rats. Kidney Int, 2001,59 : 1899-1910.
-
1赵磊,李卫国,樊亚丽.流行性出血热患者肾脏改变的B超观察[J].中原医刊,2001,28(9):35-35.
-
2吴东红,苏雁,徐滨华,程瑶,李征寒.血清脂联素与2型糖尿病肾病的临床研究[J].现代预防医学,2009,36(20):3979-3980. 被引量:3
-
3刘爱翔.流行性出血热彩色多普勒超声的肾脏改变[J].中国乡村医药,2002,9(6):10-11. 被引量:1
-
4张治平.系统性红斑狼疮患者肾脏改变与临床表现相关性研究[J].中外医学研究,2015,13(5):20-21. 被引量:3
-
5李凯.脉压对老年高血压病患者靶器官的影响[J].中国医药指南,2011,9(26):234-235. 被引量:1
-
6李巧荣.吸烟对支气管黏膜组织PPAR-γ、IL-8和TNF-α表达的影响[J].山东医药,2017,57(12):63-65. 被引量:6
-
7孙中华.原发性高血压患者血压变异与心血管事件的相关性研究[J].临床和实验医学杂志,2012,11(10):744-745. 被引量:4
-
8刘新明,刘晓城,刘慎微.羟苯磺酸钙对2型糖尿病大鼠肾脏改变的影响[J].山西医科大学学报,2005,36(1):33-35. 被引量:6
-
9王燕,李宝新,李玉坤.PPARγ与骨重建研究进展[J].生物医学工程学杂志,2011,28(1):213-216. 被引量:1
-
10薛凌,于晓玲,邱雅慧.罗格列酮、辛伐他汀合用对兔动脉粥样硬化形成的影响[J].中国微循环,2009,13(6):514-517. 被引量:1